MedTrace Logo

Everolimus Stent in Patients With Coronary Artery Disease (CAD)

NCT01182649 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2010-08-17

No results posted yet for this study

Summary

Aim of the study is to compare the everolimus eluting stent and sirolimus eluting stent in all comers PCI eligible patients

Conditions

Interventions

DEVICE

coronary stent

coronary angioplasty with stent implantation

DEVICE

stent

coronary angioplasty with stent implantation

Sponsors & Collaborators

  • San Giuseppe Moscati Hospital

    lead OTHER

Principal Investigators

  • EMILIO DI LORENZO, MD PhD · DIVISION OF CARDIOLOGY AORN MOSCATI AVELLINO ITALY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2008-12-31
Completion
2010-06-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01182649 on ClinicalTrials.gov